For mechanistic action of thee PDHK inhibitors, DCA-inhibition of PDHK1 activity transforms tumor metabolic glycolysis to phosphoryl oxidation status, consequently decreasing the resistant level of mitochondrial apoptosis [140,141]. The gene discussed is PDK1; the disease is neoplasm.